父母触摸缓解新生儿急性操作疼痛及父母焦虑:Petal多中心随机对照试验
Petal试验在英国两家医院纳入112名胎龄≥35周、生后第一周需足跟采血的新生儿,随机分为采血前(干预组)或采血后(对照组)由父母以约3 cm/s速度触摸10秒。结果显示干预组与对照组在EEG测量的伤害性诱发脑活动幅度、PIPP-R评分、心动过速发生及父母焦虑评分上均无显著差异。
要点
- PIPP-R评分、心动过速发生及父母焦虑评分在两组间均无显著差异。
- 将研究者主导的实验性触觉干预转化为父母主导方式存在挑战,但让父母参与婴儿疼痛管理仍有价值。
核心结论
- 以约3 cm/s速度触摸10秒、旨在激活C触觉纤维的父母触摸,在足跟采血前实施未能显著改变新生儿疼痛相关脑活动幅度、PIPP-R评分或心动过速发生。
研究设计与样本
- Petal为在英国John Radcliffe医院和Royal Devon and Exeter医院开展的多中心、随机、平行组、干预性优效性试验。
- 纳入胎龄≥35周、无神经系统异常、生后第一周需足跟采血的新生儿,1:1随机分配至采血前父母触摸10秒(干预组)或采血后触摸10秒(对照组)。
- 随机化在Oxford站点通过基于网络的最小化算法管理并实现分配隐藏。
- 主要结局为EEG测量的足跟采血诱发伤害性脑活动幅度;次要结局包括PIPP-R评分、心动过速发生和父母焦虑评分。
- 2021年9月1日至2023年2月7日期间,159名父母被邀请参与,最终纳入112名新生儿(干预组56名,对照组56名)。
主要发现
- 对照组一名新生儿发生一次血氧饱和度下降的严重不良事件,研究认为与试验无关。
临床怎么用
- 对于胎龄≥35周、生后第一周需足跟采血的新生儿,采血前由父母以约3 cm/s速度触摸10秒未显示显著镇痛效果,不应据此替代其他循证镇痛措施。
- 该试验提示将研究者主导的触觉干预转化为父母主导方式存在挑战,临床应继续探索有效的父母参与疼痛管理方式。
局限性
- 主要结局分析基于符合方案集且部分新生儿因EEG数据可分析性未纳入(干预组n=39,对照组n=43),可能影响把握度。
- 试验仅在英国两家医院开展,结果外推需谨慎。
- 试验将实验性触觉干预转化为父母主导方式存在挑战,可能影响干预保真度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Touch interventions such as massage and skin-to-skin contact relieve neonatal pain. The Parental touch trial (Petal) aimed to assess whether parental stroking of their baby before a clinically required heel lance, at a speed of approximately 3 cm/s to optimally activate C-tactile nerve fibres, provides effective pain relief. METHODS: Petal is a multicentre, randomised, parallel-group interventional superiority trial conducted in the John Radcliffe Hospital (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) and the Royal Devon and Exeter Hospital (Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK). Neonates without neurological abnormalities who were born at 35 weeks gestational age or more and required a blood test via a heel lance in the first week of life were randomly assigned (1:1) to receive parental touch for 10 s either before (intervention group) or after (control group) the clinically required heel lance. Randomisation was managed at the Oxford site using a web-based minimisation algorithm with allocation concealment. The primary outcome measure was the magnitude of noxious-evoked brain activity in response to the heel lance measured with electroencephalography (EEG). Secondary outcome measures were Premature Infant Pain Profile-Revised (PIPP-R) score, development of tachycardia, and parental anxiety score. For all outcomes, the per-protocol effect was estimated via complier average causal effect analysis on the full analysis set. The trial is registered on ISRCTN (ISRCTN14135962) and ClinicalTrials.gov (NCT04901611). FINDINGS: Between Sept 1, 2021, and Feb 7, 2023, 159 parents were approached to participate in the study, and 112 neonates were included. 56 neonates were randomly assigned to the intervention group of parental stroking before the heel lance and 56 to the control group of parental stroking after the heel lance. The mean of the magnitude of the heel lance-evoked brain activity was 0·85 arbitrary units (a.u.; SD 0·70; n=39; a scaled magnitude of 1 a.u. represents the expected mean response to a heel lance in term-aged neonates) in the intervention group and 0·91 a.u. (SD 0·76; n=43) in the control group. Therefore, the primary outcome did not differ significantly between groups, with a mean difference of -0·11 a.u. (lower in intervention group; SD 0·77; 95% CI -0·42 to 0·20; p=0·38; n=82). No significant difference was observed across secondary outcomes. The PIPP-R difference in means was 1·10 (higher in intervention group, 95% CI -0·42 to 2·61; p=0·15; n=100); the odds ratio of becoming tachycardic was 2·08 (95% CI 0·46 to 9·46; p=0·34, n=105) in the intervention group with reference to the control group; and the difference in parental State-Trait Anxiety Inventory-State score was -0·44 (higher in control group; SD 6·85; 95% CI -2·91 to 2·02; p=0·72; n=106). One serious adverse event (desaturation) occurred in a neonate randomly assigned to the control group, which was not considered to be related to the study. INTERPRETATION: Parental stroking delivered at an optimal speed to activate C-tactile fibres for a duration of 10 s before the painful procedure did not significantly change neonates' magnitude of pain-related brain activity, PIPP-R score, or development of tachycardia. The trial highlighted the challenge of translating an experimental researcher-led tactile intervention into a parent-led approach, and the value of involving parents in their baby's pain management. FUNDING: Wellcome Trust and Bliss.
引用
- Hauck AGV, van der Vaart M, Adams E, et al. Effect of parental touch on relieving acute procedural pain in neonates and parental anxiety (Petal): a multicentre, randomised controlled trial in the UK. Lancet Child Adolesc Health. 2024. PMID: 38373429. doi:10.1016/S2352-4642(23)00340-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。